News
Stay up to date on topics that are important to Nurse Practitioners.
-
FDA Warns of Risks Associated With Noninvasive Prenatal Screening Tests
The FDA is warning the public of the risk of false results, inappropriate use, and inappropriate interpretation of…
-
PreHevbrio Hepatitis B Vaccine Now Available for Adult Hepatitis B Vaccination
VBI’s hepatitis B vaccine (recombinant) (PreHevbrio) is now available for the prevention of infection caused by all known…
-
WHO Panel Concludes That a Single Dose of HPV Vaccine Is Protective
The World Health Organization’s Strategic Advisory Group of Experts on Immunization (SAGE) announced that there is enough evidence…
-
CDC Warns of Severe Hepatitis and Adenovirus Infections in Children
The US Centers for Disease Control and Prevention (CDC) issued a Health Alert Network Health Advisory to notify…
-
CDC: STDs Continued to Increase During First Year of COVID-19 Pandemic
The US Centers for Disease Control and Prevention (CDC) announced that sexually transmitted diseases (STDs) continued to increase…
-
FDA Approves First Sublingual Medication for Agitation in Serious Mental Illness
The FDA approved dexmedetomidine (Igalmi) sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar…
-
New York and Kansas Grant Full Practice Authority to NPs
Nurse practitioners licensed in New York and Kansas are now fully able to practice independently, joining 24 other…
-
Appropriate Antibiotic Prescribing for Acute Respiratory Infections
In 2020, healthcare providers prescribed 201.9 million antibiotic prescriptions—equivalent to 613 antibiotic prescriptions per 1,000 persons.1 Studies have…
-
FDA Approves New Indication for IL-23 Inhibitor for Adults With Active Psoriatic Arthritis
Risankizumab-rzaa (Skyrizi) is now approved for the treatment of adults with active psoriatic arthritis. It is the only…
-
Carbidopa/Levodopa Fractional Tablet Now Available for Parkinson’s Disease
A carbidopa/levodopa tablet formulation (Dhivy) designed to facilitate dose adjustment is now available for the treatment of Parkinson’s…
-
FDA Approves Treatment for Wider Range of Patients With Heart Failure
The FDA approved empagliflozin (Jardiance) to reduce the risk of cardiovascular death and hospitalization for heart failure in…
-
New Migraine Treatment Approved in Adults
Celecoxib oral solution (Elyxyb) was approved for the acute treatment of migraine with or without aura in adults.…
Trending
-
FDA Approved Semaglutide Injection to Reduce Risk of Serious Heart Problems in Overweight Adults
-
The Role of Pharmacogenomics in Precision Mental Healthcare
-
OTC COVID-19 Diagnostic Tests May Have an Extended Shelf Life
-
AANP Offers Resources to Help NPs Detect and Treat Ulcerative Colitis
-
Multistate Outbreak of Salmonella Linked to Cucumbers
-
5 Key Benefits of Getting a Second Certification as a Nurse Practitioner
-
8 Key Tips for Effective Communication During Pediatric ENT Exams
-
Normalizing Anxiety: How NPs Can Guide Patients to Make Healthier Choices
-
CDC Endorses Lowering Pneumococcal Vaccination Age from 65 to 50
-
FDA Proposes Ban on Over-the-Counter Oral Nasal Congestion Medication
-
Using Technology to Combat Drug-Drug Interactions
-
Building a Strong Professional Nursing Network as a New Nurse Practitioner
Join our email list
Get new course alerts, newsletters and more delivered directly to your inbox
By providing my personal information, including phone number, I consent to (1) receive email messages with information and offers, autodialed calls, texts, and prerecorded messages from FHEA, including current and possible future services, customer service and billing; and (2) FHEA’s Privacy Policy and Terms and Conditions. I understand that my consent is not required to purchase, and that cancellation of purchase does not automatically revoke this consent.